Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Ken Kershner and Warren Kibbe


DNANexus has hired Ken Kershner to serve as its vice president of engineering. In this role, he will be responsible for leading the company's development and product quality teams and will oversee the architecture and technology powering the company’s cloud service for DNA data analysis and management.

Kershner joins DNAnexus from MobileIron, where he was vice president of engineering and operations. He has also held senior engineering positions at Dash Navigation, TiVo, TenTV, Silicon Graphics, and Hewlett Packard.

He obtained an MBA in the management of technology innovation from the Sloan School of Management at the Massachusetts Institute of Technology and a BS in electrical engineering from Duke University.

The National Cancer Institute has tapped Warren Kibbe to head its Center for Biomedical Informatics and Information Technology starting on October 1, 2013.

Kibbe is a professor of medicine and head of the bioinformatics program at Northwestern University. He's also the director of cancer informatics for Northwestern's cancer center and co-director of the university's biomedical informatics center.

He is a member of the open biomedical ontologies community and is part of the Gene Ontology Consortium and the CTSA Ontology Working Group. He was a founder and principal investigator of a National Institute's of Health-funded project to build the Human Disease Ontology. Kibbe was the PI of the caBIG Patient Study Calendar module software development project, which developed a syntactically and semantically harmonized interoperable patient study calendar. He is also the co-PI of the Dictyostelium Model Organism Database, dictyBase.

Kibbe obtained a BS in chemistry from Michigan Technological University and a PhD in chemistry from California Institute of Technology.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.